Plough,Time will tell as to whether there has been a paradigm shift.Somehow I think it is just more of the same, long on promises, short on delivery.Happy for you if you prove me wrong as I am well out of this one and glad to be so.Archview
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential